Compositions and methods for hepatoprotection and treatment of cholestasis
US6987121B2 · kind B2 · utility
61Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 25, 2002 |
| Grant date | Jan 17, 2006 |
| Priority date | — |
| Expiry date | Aug 14, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for the treatment of cholestatic liver disease and reduction and prevention of hepatic injury resulting from cholestasis via administration of a FXR ligand are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.